Dianthus Therapeutics Inc. (DNTH)
Healthcare
Biotechnology
—
106.90 $
-5.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Dianthus Therapeutics Inc. (DNTH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -29 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.7 | 1.5 | -12 | -15 | -15 | -21 | -27 | -28 | -24 | -31 | -47 | -29 | -130 | |
| 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.4 | |
| 0.5 | 1.2 | 0.7 | 2.0 | 3.1 | 3.8 | 3.9 | 5.3 | 5.7 | 5.8 | 6.0 | 11 | 28 | |
| 0.3 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 6.1 | 10 | -1.6 | -2.8 | 0.3 | 2.6 | -0.4 | -1.7 | 3.1 | 2.9 | 12 | 2.2 | 21 | |
| 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.2 | |
| 22 | -17 | -8.2 | -5.5 | 1.2 | -259 | -23 | 15 | 26 | -201 | 37 | -134 | -272 | |
| – | – | – | – | – | -50 | – | – | – | – | 0.3 | 0.1 | – | |
| – | – | – | – | – | 0.0 | 0.0 | – | – | – | – | – | – | |
| 0.0 | 154 | -4.9 | 218 | -2.2 | 0.3 | 40 | 0.2 | 0.6 | 275 | 4.9 | 739 | 1,019 | |
| 17 | 95 | -25 | 197 | -16 | -280 | -11 | -13 | 3.1 | 43 | -4.9 | 577 | 617 | |
| -4.8 | 1.6 | -12 | -15 | -15 | -21 | -27 | -28 | -24 | -31 | -47 | -29 | -130 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.